AGP Picks
View all

Press Releases

Stay up to date with press releases covering announcements, company news, product launches, and business updates.

Publish your press release
fallback image
Feb. 5, 2026

Colombia’s Senate urged to pass bill on female genital mutilation before legislative deadline

EIN Presswire

fallback image
Mar. 30, 2026

Chiesi Global Rare Diseases Receives Positive CHMP Opinion for LOJUXTA® (lomitapide) ▼ Capsules for Paediatric Use in Homozygous Familial Hypercholesterolemia (HoFH)

GlobeNewswire, Inc.

fallback image
Mar. 30, 2026

SS Innovations Expands Global Opportunity with Regulatory Approval of the SSi Mantra Surgical Robotic System in Colombia, Oman, Sri Lanka and Kenya

GlobeNewswire, Inc.

fallback image
Mar. 24, 2026

Tatwa Integrative Medicine Establishes Itself as Europe's Reference for Amazonian Floral Essences and Launches Its 10th Vibratory Elixir

GlobeNewswire, Inc.

fallback image
Jul. 17, 2026

Fetal Bovine Serum Market Worth USD 6.05 Billion by 2023, Expanding at 14.0% CAGR | 2026–2033 Forecast

EIN Presswire

fallback image
Mar. 16, 2026

George Medicines extends global commercialization of GMRx2 into Australia and New Zealand with Arrotex licensing agreement

GlobeNewswire, Inc.

fallback image
Jul. 17, 2026

Telehealth Market Set to Booming Growth 2026-2033 | McKesson Corporation, Medvivo Group Ltd

EIN Presswire

fallback image
Jul. 20, 2026

CORRECTION - Terra Innovatum Global N.V.

GlobeNewswire, Inc.

fallback image
Jul. 17, 2026

Palm Oil Market to Surpass USD 112.91 Billion by 2033, Expanding at 5.9% CAGR | 2026–2033 Forecast

EIN Presswire

fallback image
Mar. 11, 2026

George Medicines signs exclusive licensing agreement with Ahngook Pharmaceutical to commercialize GMRx2 in Korea

GlobeNewswire, Inc.

fallback image
Jul. 20, 2026

Terra Innovatum Signs Commercial LOI with Waiken ILW for Deployment of SOLO™ Microreactors at DIRECTV Latin America Data Center Facilities

GlobeNewswire, Inc.

fallback image
Mar. 9, 2026

Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce European Commission Approval of Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) ▼

GlobeNewswire, Inc.

fallback image
Jul. 10, 2026

Five Reputable Titanium Bar Manufacturers Worldwide 2026: Delivering High-Strength Metallic Raw Materials

EIN Presswire

fallback image
Mar. 9, 2026

Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce European Commission Approval of Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa)

GlobeNewswire, Inc.

fallback image
Mar. 3, 2026

Chiesi Global Rare Diseases Announces FDA Approval of JUXTAPID® (lomitapide) Capsules for Pediatric Use in Homozygous Familial Hypercholesterolemia (HoFH)

GlobeNewswire, Inc.

fallback image
Feb. 25, 2026

George Medicines advances its global commercial strategy for GMRx2 with an exclusive licensing agreement with Orient EuroPharma in Southeast Asia

GlobeNewswire, Inc.

fallback image
Feb. 25, 2026

ICPO Foundation and the World Federation of Nuclear Medicine and Biology (WFNMB) cooperate to advance Theranostics worldwide

GlobeNewswire, Inc.

fallback image
Feb. 24, 2026

Sofía Vergara’s ¡Dios Mío! Coffee Makes Waves at SOBEWFF® 2026 with Women-Grown Colombian Coffee

EIN Presswire

fallback image
Mar. 3, 2026

MPD Makes Arrests in a Colombia Heights Assault

Metropolitan Police Department - Washington D.C.

fallback image
Feb. 25, 2026

CGS Nexus Doubles the Size of Its BPO Operation in Colombia

GlobeNewswire, Inc.

Sign up for:

Health News Hub Colombia

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by: